Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Woman, 60, Is Finally Traveling the World Decades After Husband’s Death Held Her Back - 2Survey: Protected And Versatile Men's Razor
- 3What's going on with Katseye? The Manon Bannerman hiatus drama, explained.
- 4World's oldest known tortoise still very much alive despite rumor to the contrary
- 5Figure out How to Explore Land Close to 5G Pinnacles
- ‘Risk children’s lives for some extra manpower’: IRGC recruits 12 year olds to fill personnel gaps
- Figure out How to Reveal Stowed away Open Record Rewards
- The Delight of Perusing: Book Proposals for Each Class
- Indian Health Service is digging out of decades-old construction backlog for medical buildings
- Putin says Russian forces will seize capital of Zaporizhzhya
- Instructions to Warmly greet Certainty and Appeal
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- What you need to know about desalination, a growing source of drinking water
- Quandoo to shut restaurant booking platform by end of 2026
